Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smuts, C. M.
Right arrow Articles by Benadé, A. J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smuts, C. M.
Right arrow Articles by Benadé, A. J. S.
© 2005 The American Society for Nutritional Sciences J. Nutr. 135:653S-659S, March 2005


International Research on Infant Supplementation: Randomized Controlled Trials of Micronutrient Supplementation During Infancy

Efficacy of Multiple Micronutrient Supplementation for Improving Anemia, Micronutrient Status, and Growth in South African Infants1,2

Cornelius M. Smuts3, Muhammad A. Dhansay, Mieke Faber, Martha E. van Stuijvenberg, Sonja Swanevelder*, Rainer Gross** and A. J. Spinnler Benadé

Nutritional Intervention Research Unit and * Biostatistics Unit, MRC, Parow, South Africa, and ** UNICEF, New York, NY

3To whom correspondence should be addressed. E-mail: marius.smuts{at}mrc.ac.za.


    ABSTRACT
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Growth faltering, anemia, and multiple micronutrient deficiency are common during infancy in developing countries. This South African trial was part of a multicenter study aimed at testing the efficacy of multiple micronutrient supplementation on growth, anemia, micronutrient status, and morbidity during infancy across 4 countries. A total of 265 infants aged 6–12 mo were individually randomized to 1 of 4 intervention groups: a daily multiple micronutrient supplement (DMM), a daily placebo supplement (P); a multiple micronutrient supplement 1 d of the week and placebo supplement on the other days of the week (WMM), and a daily iron supplement (DI). For 6 mo, the blinded supplements were provided to mothers at monthly health clinic sessions, and consumption was verified during weekly household visits by community health workers, when morbidity was also checked. Weight and height of the infants were measured monthly, and blood samples were taken at the beginning and at the end for assessing the infants micronutrient status. There were no significant differences in nutritional status of the groups at baseline with 40% of infants with anemia (hemoglobin < 110 g/L), 16% vitamin A deficiency (plasma retinol < 0.7 µmol/L), 47% zinc deficiency (plasma zinc < 10.7 µmol/L), 2% underweight, and 11% stunting. There was no difference in growth or morbidity between the micronutrient supplemented groups and the P group during the 6-mo study. The DMM was the most effective intervention tested, not only for improving anemia but also for improving iron, zinc, riboflavin, and tocopherol status.


KEY WORDS: • iron • zinc • multiple micronutrient supplementation • infant’s growth • anemia

In the developing world, many vulnerable population groups suffer from multiple micronutrient deficiencies, and iron, vitamin A, and iodine are the ones most commonly reported. Infants are likely to have multiple, concurrent deficiencies, because the same causative factors are responsible for deficiency of different micronutrients. The cereal-based diets commonly consumed in developing countries are rich in phytate and low in animal products, predisposing people to insufficient absorption of both iron and zinc (1), and low intakes of several vitamins.

In South Africa, a national survey in 1994 showed that, for children aged 6–71 mo, the prevalence of marginal vitamin A deficiency (serum retinol < 0.7 µmol/L) and anemia [hemoglobin (Hb)4 < 110 g/L] was 33% and 20%, respectively. However, in the age category 6–11 mo, the prevalence of anemia was 48%; 25% of the children were stunted, whereas 10% were underweight. Interprovincial differences were observed, and children living in rural areas, whose mothers had low educational levels, were affected the most (2). A national food consumption survey showed that the great majority of children in South Africa consumed a diet of poor nutrient density, with the nutrient intake of those living in rural areas being considerably poorer than that of children living in urban areas (3).

Adequate intakes of iron, vitamin A, zinc, iodine, and other micronutrients are essential for growth, as well as mental and motor development, and for the prevention of disease. Children with micronutrient deficiencies often present with linear growth retardation, higher morbidity and mortality, and reduced psychomotor development, such that those who survive have less possibility of developing to their full potential (4,5). Exclusive breast-feeding is considered sufficient to provide adequate nutrition for infants during the first 6 mo of life (6). However, the transition to complementary foods in the process of weaning children to household diets is associated with greatly increased risks of nutrient deficiencies (7), due to the low density and/or poor bioavailability of certain nutrients in some household diets. It is well known that anemia is common in infants even in industrialized nations (8,9) and that obtaining sufficient zinc from dietary sources is a challenge in most settings (7). The consequence may be widespread prevalence of deficiencies of iron, zinc, and other micronutrients from 7 mo of age onward, especially in low-income societies (10,11). Providing for optimal nutrition status of infants born under the least favorable socioeconomic and climatic conditions would require exclusive breast-feeding during the first 6 mo of life, with the possible application of routine dietary enrichment and/or supplementation with selected micronutrients during the period of weaning transition (12).

Combining multiple micronutrients in a single delivery mechanism has been suggested as a cost-effective way to achieve multiple benefits (13,14). Some studies have questioned the effectiveness of nutrients combined within a supplement because of possible interactions among the nutrients and interference in their absorption (15,16). The aim of the study was to investigate the efficacy of multiple micronutrient supplementation (daily and weekly) on the micronutrient, anthropometric, and morbidity status of infants. A weekly supplement compared with a daily supplement was included because of data showing that intermittent (e.g., weekly) micronutrient supplementation could be less expensive and easier for participants to follow (17). Finally, a daily iron-only treatment group was added to identify any effects of other vitamins and minerals on iron absorption and metabolism.


    SUBJECTS AND METHODS
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Study site

The study was carried out in the Valley of a Thousand Hills, situated ~40 km northwest of the coastal city of Durban in the KwaZulu-Natal Province, South Africa. This is a rural area with an estimated population of 200,000 people. The population density is low, because the families are scattered over a large mountainous area. The study was done through the Community Based Health Programme of The Valley Trust, a nongovernmental organization that operates through 12 health posts and that has >100 community health workers.

Subject selection and study design

Infants aged 6–12 mo were recruited through the health posts. The sample size was calculated based on the comparison of a fall in standardized weight for age from –0.65 to –0.95 for the daily multiple micronutrient supplement (DMM) group compared with a fall from –0.65 to –1.20 in the placebo (P) group. For a two-group repeated measures ANOVA with 7 levels (mo 0 to 6) a sample size of 256 per group will provide the analysis with 80% power when the significance level is 5%. The aim was to include at least 70 infants per group (65 + 5 dropouts). We enrolled 290 infants into the study. Exclusion criteria included premature birth (<37 wk gestation), low birth weight (<2500 g), severe wasting [<–3 weight-for-height Z-score (WHZ)], Hb < 80 g/L, and fever (>39°C) on the day of blood sampling, as described in further detail by Smuts et al. (18).

The study had a randomized, double-blind, placebo-controlled design. Children were randomly assigned to 1 of 4 intervention groups using a simple computer program provided to all participating countries. Group 1 (DMM) received a daily supplement containing 1 daily allowance of multiple micronutrients for young children. Group 2 (P) received a daily placebo supplement containing no micronutrients. Group 3 (WMM) received a weekly supplement containing 2 daily allowances of multiple micronutrients for young children and a placebo supplement on the other days of the week. Group 4 (DI) was given a daily supplement containing 10 mg of elemental iron.

Supplements

Roche Laboratories was responsible for the final blend of the product, and a private laboratory in Peru (Hersil SA) for the production and quality control of the supplements. The supplements were manufactured as large chewable tablets or foodlets, which were easy to break and dissolve. A week’s supply of foodlets was wrapped in identical coded blister packs, and all foodlets had the same taste, color, and flavor. Three of the groups (P, DI, and DMM) had blisters with 7 foodlets, and, within each group, all foodlets had the same composition; the 4th group (WMM) had blisters that included 6 placebo foodlets and one 2-daily-allowance foodlet always placed in the same position within the blister arrangement. Codes were kept by UNICEF (United Nations Children’s Fund), New York, and were revealed at the end of the study, during the final statistical analyses at the Medical Research Council in South Africa.

Consumption of foodlets

Blister packs and working materials were color coded to facilitate and simplify the identification of groups. Because the houses were scattered over a large mountainous area, it was impossible for the community health workers to visit each household every day. Therefore mothers were provided with a 1 mo foodlet supply. Each mother received a color-coded container to store the foodlets. The mothers and/or caregivers were given demonstrations on how to crumble and mix the foodlet with porridge. Mothers were trained to mix foodlets with a small quantity of porridge (predominantly maize meal), because it was important that the child should eat the entire portion mixed. The community health workers monitored compliance using a short questionnaire and observation during weekly visits. The number of foodlets removed from the previous week’s blister pack was counted and recorded. This recorded compliance was verified retrospectively by means of a questionnaire to both the caretakers and community health workers at the end of the study.

Measurements

    Questionnaire. The questionnaire was developed according to the recommendations of Gross and Schultink (19) and comprised 4 different sections: 1) the household questionnaire, which was used at baseline only; 2) the monthly weight and height recording form, which also included the date of measurement; 3) the weekly health visit recording form; and 4) the weekly health and infant feeding information questionnaire.

    Anthropometry. Infants’ anthropometric measurements were measured on a monthly basis. With subjects in light clothing, weight was recorded to the nearest 50 g on a load-cell-operated digital scale (UC-300 Precision Health Scale; A and D Instruments). Recumbent body length was measured to the nearest 0.1 cm on a horizontally placed measuring board. To exclude individual variation, all anthropometric measurements were taken by the same field worker. The anthropometric data and the age of the child were used to yield 3 measures of nutritional status: height-for-age, weight-for-age, and weight-for-height, which were expressed as Z-scores using the United States National Center for Health Statistics median as reference (20). Children with height-for-age Z-score (HAZ), weight-for-age Z-score (WAZ), and WHZ Z-score <–2 SD of this reference median were classified as stunted, underweight, and wasted, respectively. WHZ > 2 SD was classified as overweight for height.

    Blood sampling and biochemical analyses. Blood (3 mL) was collected in heparinized tubes via antecubital venipuncture. Hb concentrations were determined in the field with the cyanomethemoglobin method using a portable photometer. The rest of the blood was immediately centrifuged, and the plasma was stored at –20°C for the duration of the fieldwork (±10 d). Care was taken to limit the exposure of the samples to direct light. After completion of the fieldwork, the samples were stored at –80°C until shipped to Germany on dry ice, where they were analyzed in the Micronutrient Laboratory of the Institute of Biological Chemistry and Nutrition at the University of Hohenheim. Plasma ferritin was measured by a standard sandwich ELISA procedure from the provider of the antibodies (DAKO). Plasma zinc concentrations were analyzed by flame atomic absorption spectrophotometry, according to the description of the manufacturer (Perkin Elmer). Plasma retinol and tocopherol levels were analyzed according to Erhardt et al. (21). Plasma homocysteine levels were measured by HPLC (22), and riboflavin status was assessed by calculating the activation coefficient of the erythrocyte glutathione reductase (EGRAC) with and without added riboflavin (23). C-reactive protein (CRP) and {alpha}-1-acid glycoprotein (AGP) were measured as indicators of short- and long-term infection, respectively, by means of a Sandwich ELISA (DAKO). More detail is given elsewhere (18).

    Morbidity. Morbidity data were collected on a weekly basis during the 6-mo intervention period. Indicators recorded were whether the child suffered from diarrhea (more than 4 runny stools) or acute respiratory infection (cough, runny nose, fever, earache, or sore throat) during the week of visit, and if the child had fever on the day of the visit. The data were used to calculate the percentage of child contacts positive for each of the 3 morbidity indicators.

Ethical considerations

The Ethics Committee of the South African Medical Research Council approved the study, and permission was obtained from local community leaders. Written informed consent was obtained from the mother or the guardian of all participating infants, after a detailed explanation of the purpose of the study.

Statistical analysis

Descriptive statistics on the change from baseline to postintervention were obtained. All biochemical variables had a normal distribution, except plasma ferritin. Analysis of variance was done on variables with normal distributions to test whether there were significant group differences (F-test) and the Dunnett’s t test to specifically test whether each of the 3 supplementation groups differed significantly from the P group. Anthropometric data were treated similarly, except that height and weight gains were calculated per week. For the P, WMM, and DMM groups, tests for linear or quadratic dose effects were also done. Coefficients were specified to take into account either a linear increase or a quadratic increase in supplementation over the 7-d period.

Because infection can affect blood concentrations of micronutrients, cases with elevated plasma C-reactive protein at baseline (CRP > 12 mg/L) were excluded from the statistical analysis for plasma ferritin, retinol, and zinc (DMM group, n = 4; P group, n = 6; WMM group, n = 11, and DI group, n = 13). The logarithmic transformation was used for ferritin and this transformed scale was used for all analyses with this variable.


    RESULTS
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
The trial participant profile is given in Figure 1. A total of 290 infants were recruited. However, a delay in the manufacturing and the delivery of the foodlets resulted in 36 babies being excluded from the study before implementation, because they no longer fit into the specified age category of 6–12 mo. A further 11 babies were recruited during implementation in the age category 6–7 mo. Of the final 265 infants included in the study, 194 infants completed the trial (27% dropout). Data collected weekly showed an overall compliance of 93% (P, 94%; WMM, 94%; DMM, 93%; and DI, 92%). Retrospective data showed that the caregivers indicated 95% compliance, whereas the community health workers perceived that at least 90% of infants took the foodlets daily.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 1 Trial profile. Dropout rate = 27%.

 
The demographic characteristics of the study populations are given in Table 1. There were no significant differences among the treatment groups based on education, unemployment, and provision of basic services. More than 65% of mothers and fathers had a high-school education. The unemployment rate for the head of the household was >20%. On average, >70% households were supplied with public water and electricity.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Demographic indicators of study population at baseline by treatment group

 
Baseline characteristics of recruited infants are given in Table 2. The average age of the 194 infants that participated in the study was 8.4 ± 2.0 mo at baseline. Blood samples were analyzed for the 194 children that completed the study. Anemia (Hb < 110 g/L) was, on average, present in 40% and vitamin A deficiency (plasma retinol < 0.7 µmol/L) in 16% of infants. Zinc deficiency occurred in 47% of infants. The overall prevalence of elevated CRP (>12 mg/L) and AGP (>1 g/L) values was 12% and 42%, respectively. The prevalence of underweight and stunting was 2% and 11%, respectively. Overweight (WHZ > 2SD) was present in 20% of infants (results not shown).


View this table:
[in this window]
[in a new window]
 
TABLE 2 Characteristics of infants at baseline by treatment group

 
The weights and the heights at baseline and at the end of the intervention period, as well as the Z-scores are presented in Table 3. The WAZ and the WHZ decreased during the 6 mo in all groups, except in the DMM group. The HAZ decreased significantly in all the groups during the intervention period. There was no difference in the absolute changes in mean weight and height during the 6 mo of the trial in the treatment groups compared with the P group.


View this table:
[in this window]
[in a new window]
 
TABLE 3 Anthropometric indices [mean (SD)] at baseline, final measure, and changes from baseline by treatment group

 
The concentrations of Hb, ferritin, retinol, zinc, homocysteine, riboflavin, and tocopherol at baseline and at the end of the study, as well as the change over the 6 mo of intervention, are presented in Table 4. Hb increased significantly in the DMM group over the 6 mo, and the absolute change in Hb concentration was significantly higher in the DMM group than in the P group. The log ferritin values after 6 mo were significantly lower than at baseline in the P and WMM groups, and the absolute change was significantly greater in the DMM and DI groups compared with the P group. Plasma zinc concentrations rose significantly in the DMM group, yet tended to fall in P and DI groups, such that the absolute change in level over the 6-mo period was significantly greater in the DMM than in the P group. The increase in EGRAC over time was significant in the P and DI groups, and the change in the level of activation was greater in the DMM group compared with the P group. Homocysteine concentrations decreased significantly over 6 mo in the DMM and WMM groups, with the change greater in DMM than in P. Tocopherol concentrations fell in all groups, although significantly so in the P and WMM groups, and the size of the absolute change was smallest in the DMM and DI groups.


View this table:
[in this window]
[in a new window]
 
TABLE 4 Micronutrient status [mean (SD)] at baseline and final measure, and mean (±SE) changes from baseline, by treatment group

 
The morbidity data (Table 5), expressed as the prevalence of fever on the day of contact with the health worker, and incidence of diarrhea and acute respiratory infection reported during the previous week, showed no group differences. Diarrhea was the most prevalent illness reported.


View this table:
[in this window]
[in a new window]
 
TABLE 5 Incidence of specific morbidities in study infants during the previous week (%) as reported by mothers to health workers, and prevalence of fever on the day of contact (%), by treatment groups

 

    DISCUSSION
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
None of the groups supplemented showed any significant difference in linear growth when compared with the P group, and therefore the micronutrient supplements did not prevent the deterioration in anthropometric status commonly seen in this age group in Africa (24,25). The International Research study on Infant Supplementation (IRIS) study was a multicenter trial, and the design required the data of the 4 participating countries to be collated when measuring the main outcomes. Although the sample size was at the country limits for the calculation of statistically significant outcomes for anthropometry, a larger sample size would not have changed the result for length growth in South African infants. A similar finding was observed in a 6-mo, fortified (iron, retinol, and zinc), complementary food intervention trial in 6-mo-old infants (26) and after iron only or iron plus zinc supplementation in Mexican preschoolers (27). This is contradictory to another study on Mexican infants that showed greater length gain after daily, one recommended dietary allowance multiple micronutrients for 12 mo compared with the P group, although this was only in those infants aged <12 mo of age (28). Possible explanations for a lack of growth response to micronutrient supplementation are the shorter supplementation period (only 6 mo) and the relatively low prevalence of stunting in the infants in the South African study population.

The DMM intervention was the most efficacious treatment for improving anemia during infancy in this South African setting. This study supports the conclusion made by Beaton and McCabe (29) that daily supplements containing iron are more efficacious than intermittent supplementation for treating anemia. Although there was some improvement in Hb status in all 3 nonplacebo groups and there was a significant decrease in the prevalence of anemia in both the DMM and DI treatment groups, the treatment effect was only significant for the DMM supplement. The adequate vitamin A status possibly enabled the Hb response to both multiple micronutrient and iron treatments of iron deficient infants (30,31). van Stuijvenberg et al. (32) noted that responses to iron fortification are limited in children with marginal vitamin A status. The improved effect of the multiple micronutrient supplement on reducing anemia compared with iron alone could also be due to other micronutrients in the supplement, including riboflavin, B-12, and folic acid, which have been shown to have an enhancing effect on the metabolism of iron or synthesis of Hb (3336).

The DMM supplement was the best treatment for improving both zinc and iron status of the infants. Although plasma ferritin, which is an indicator of iron stores, showed no improvement in any of the treatment groups, there was a significant deterioration in the P group, which resulted in a significant treatment effect being detected in both the daily multiple micronutrient and iron only groups. These supplements thus prevented the deterioration in iron stores as the infant grew older. The treatment effect for ferritin was slightly but nonsignificantly larger in the iron only group, possibly suggesting lack of interference from other micronutrients that may compete with iron for absorption, e.g., zinc (37). However, it could also have been that the presence of vitamin A in the multiple micronutrient supplement mobilized more of the storage iron for hematopoiesis (38), based on the slightly (but not significantly) greater change in the multiple micronutrient supplementation group. DMMs significantly increased the plasma zinc concentration from baseline to the end of the study and compared with the P group. This indicates that the DMMs more effectively improved zinc status compared with the other treatment groups. In general, there was a significant dose response effect observed for zinc when the DMM, WMM, and P treatments were compared.

The DMM supplement was the best intervention tested for improving both the fat-soluble and the water-soluble vitamin status of the infants. Plasma retinol only showed an increase in the DMM group, although this was not significant. With an overall plasma retinol concentration of 0.99 µmol/L at baseline and only 16% of infants being vitamin A deficient, a greater effect could not be expected. It is likely that this relatively adequate vitamin A status is a reflection of breast-feeding practices, with 60% of mothers still giving more than 3 breast-milk feedings a day at baseline. Tocopherol concentrations fell in all groups over the 6 mo of the trial, with the greatest protection in the group receiving multiple micronutrients daily. These falling vitamin E levels are of concern and suggest that the tocopherol status of the mothers and the amounts passing to the infants in breast milk are suboptimal.

Whereas, riboflavin status of the infants receiving multiple micronutrients improved, the status of the DI and P groups got worse during the course of the study. Similarly homocysteine concentrations were lowest in the infants that received multiple micronutrient supplements daily, and the decrease over time was significantly less in the P group than in the DMM group. Homocysteine concentrations depend largely on folate, vitamin B-6, vitamin B-12, and riboflavin status, and are elevated if any one of these is limiting. A study on adults in West Africa has shown that their high levels of circulating homocysteine were related to limited folate rather than B-12 status (39). The amounts of folic acid and B-12 provided by the DMM supplements seem sufficient to ensure adequate folate and B-12 status, although we cannot be sure which were limiting in the other groups.

The issues of compliance and dropout rates are unlikely to have introduced any bias in the results of the study, and the supplements were generally well received. Although designed to be a true efficacy study, because the households were scattered over a large mountainous area, the health workers could not visit each house and observe the foodlets consumption on a daily basis. The information collected weekly from the mothers by the health workers was largely confirmed by the retrospective data collected at the end of the study by the research team. The positive effect on plasma micronutrient status and the dose–response effects observed are also supportive of the reported compliance rate of >90%. The dropout rate in the IRIS study in South Africa over the 6-mo intervention period was unexpectedly high, mainly because the study ran through the festive season. The dropout rate tripled from 9% to 27% over this period, but the infants who dropped out were not significantly different in terms of baseline characteristics from the rest of their groups (results not shown). In the beginning, there were some complaints that infants were nauseous after taking the supplements, but these complaints disappeared after the community health workers provided encouragement and encouraged mothers to mix the supplement in the porridge.

Diarrhea was the most prevalent morbidity indicator noted, with an average prevalence of >20% for the entire 6-mo intervention period. In previous studies done by our group, the prevalence of diarrhea was 16% for 4- to 12-mo-old babies in a neighboring rural village (40) and 28% in an urban setting near Cape Town (41). The high rate of infections was also confirmed by the prevalence of increased acute-phase proteins, namely, CRP and AGP. The lack of effect of multiple micronutrient or iron-only supplementation on morbidity differs from results of other studies where micronutrient supplementation reduced morbidity (27,42,43).

In conclusion, although the multiple micronutrient supplements did not prevent growth faltering during infancy, they were successful at improving micronutrient status in this South African infant population. The DMM supplement was the most efficacious for preventing anemia and improving status of iron, zinc, riboflavin, and tocopherol.


    ACKNOWLEDGMENTS
 
We thank Mrs. Martelle Marais, Mr. De Wet Marais, and Mr. Eldrich Harmse for their excellent technical support; Dr. Carl Lombard for his input on the statistical analysis; Mr. Michael Phungula and our nutrition monitors for excellent support; The Valley Trust for its assistance; and, most importantly, the children and mothers who participated in the study.


    FOOTNOTES
 
1 Published in a supplement to The Journal of Nutrition. The research and supplement publication were supported by UNICEF. The contents are the sole responsibility of the authors and do not represent the official views of UNICEF. Guest Editors were Roger Shrimpton, Institute of Child Health in London, and Lindsay Allen, University of California, Davis. Back

2 Supported by UNICEF as part of a multicenter International Research study on Infant Supplementation. Back

4 Abbreviations used: AGP, {alpha}-1-acid glycoprotein; CRP, C-reactive protein; DI, daily iron supplement; DMM, daily multiple micronutrient supplement; EGRAC, erythrocyte glutathione reductase activation coefficient; HAZ, height-for-age Z-score; Hb, hemoglobin; IRIS, International Research on Infant Supplementation; P, Placebo; UNICEF, United Nations Childrens’ Fund; WAZ, weight-for-age Z-score; WHZ, weight-for-height Z-score; WMM, weekly multiple micronutrient supplement. Back


    LITERATURE CITED
 TOP
 ABSTRACT
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 

1. Ferguson, E. L., Gibson, R. S., Opare-Obisaw, C., Ounpuu, S., Thomson, L. U. & Lehrfeld, J. (1993) The zinc nutriture of preschool children living in two African countries. J. Nutr. 123:1487-1496.

2. South African Vitamin A Consultative Group (SAVACG) (1996) Anthropometry, vitamin A, iron and immunization coverage status in children aged 6–71 months in South Africa, 1994. S. Afr. Med. J. 86:354-357.[Medline]

3. Labadarios, D., Steyn, N., Maunder, E., MacIntyre, U., Swart, R., Gericke, G., Huskisson, J., Dannhauser, A., Voster, H. H. & Nesamvuni, A. E. (2001) The National Food Consumption Survey (NFCS): Children Aged 1–9 Years, South Africa, 1999 2001 Stellenbosch University Cape Town, South Africa.

4. Kikafunda, J. K., Walker, A. F., Collett, D. & Tumwine, J. K. (1998) Risk factors for early childhood malnutrition in Uganda. Pediatrics 102:E45.[Medline]

5. Vazir, S., Naidu, A. N. & Vidyasagar, P. (1998) Nutritional status, psychosocial development and the home environment of Indian rural children. Indian Pediatr. 35:959-966.[Medline]

6. Baumslag, N. & Favin, M. (1992) Do Infants Under Six Months of Age Need Extra Iron? A Probe. Working Paper #12 1992 MotherCare, John Snow Inc. Arlington, VA.

7. Brown, K. H., Dewey, K. G. & Allen, L. H. (1998) Complementary Feeding of Young Children in Developing Countries 1998 WHO Geneva, Switzerland.

8. Dallman, P. & Siimes, M. (1979) Iron Deficiency in Infancy and Childhood 1979 The International Nutritional Anemia Consultancy Group Washington, DC.

9. Yip, R. (1994) Iron deficiency: contemporary scientific issues and nutritional programmatic approaches. J. Nutr. 124:1479S-1490S.

10. Ramakrishnan, U. (2002) Prevalence of micronutrient malnutrition worldwide. Nutr. Rev. 60:S46-S52.[Medline]

11. Chakravarty, I. & Sinha, R. K. (2002) Prevalence of micronutrient deficiency based on results obtained from the National Pilot Program on Control of Micronutrient Malnutrition. Nutr. Rev. 60:S53-S58.[Medline]

12. Gross, R. (2001) Micronutrient Supplementation Through the Life Cycle 2001 UNICEF New York, NY.

13. Briend, A. (2001) Highly nutrient-dense spreads: a new approach to delivering multiple micronutrient to high-risk groups. Br. J. Nutr. 85(suppl. 2):S175-S179.

14. Alnwick, D. (1998) Weekly iodine supplements work. Am. J. Clin. Nutr. 67:1103-1104.[Medline]

15. Argiratos, V. & Samman, S. (1994) The effect of calcium carbonate and calcium citrate on the absorption of zinc in health female subjects. Eur. J. Clin. Nutr. 45:198-204.

16. Allen, L. H. (1998) Iron-Ascorbic Acid and Iron-Calcium Interactions and Their Relevance in Complementary Feeding: Micronutrient Fortification of Complementary Foods 1998 International Life Sciences Institute Washington, DC.

17. Gross, R., Angeles-Agdeppa, I., Schultink, W., Dillon, D. & Sastromanidjojo, S. (1997) Daily versus weekly iron supplementation: programmatic and economic implications for Indonesia. Food Nutr. Bull. 18:64-70.

18. Smuts, C. M., Benadé, A.J.S., Berger, J., Hop, L. T., López de Romaña, G., Untoro, J., Karyadi, E., Erhardt, J. & Gross, R. (2003) IRIS I: a foodlet-based multiple-micronutrient intervention in 6- to 12-month-old infants at high risk of micronutrient malnutrition in four contrasting populations. Description of a multicenter trial. Food Nutr. Bull. 24:S27-S33.

19. Gross, R. & Schultink, W. (1997) Micronutrient deficiency in urban Indonesia. Arch. Latinoam Nutr. 47:50-53.

20. Hamill, P.V.V., Drizd, T. A., Johnson, C. L., Reed, R. B., Toche, A. F. & Moore, W. M. (1979) Physical growth; National Center for Health Statistics percentiles. Am. J. Clin. Nutr. 32:607-629.[Abstract/Free Full Text]

21. Erhardt, J. G., Mack, H., Sobeck, U. & Biesalski, H. K. (2002) ß-Carotene and {alpha}-tocopherol concentration and antioxidant status in buccal mucosal cells and plasma after oral supplementation. Br. J. Nutr. 87:471-475.[Medline]

22. Pfeiffer, C. M., Huff, D. L. & Gunter, E. W. (1999) Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin. Chem. 45:290-292.[Free Full Text]

23. Bayoumi, R. A. & Rosalki, S. B. (1976) Evaluation of methods of coenzyme activation of erythrocyte enzymes for detection of deficiency of vitamins B1, B2, and B6. Clin. Chem. 22:327-335.[Abstract/Free Full Text]

24. Faber, M., Jogessar, V. B. & Benade, A.J.S. (2001) Nutritional status and dietary intakes of children aged 2–5 years and their caregivers in a rural South African community. Int. J. Food Sci. Nutr. 52:401-411.[Medline]

25. Hautvast, J.L.A., Tolboom, J.J.M., Kafwembe, E. M., Musonda, R. M., Mwanakasale, V., van Staveren, W. A., van’t Hof, M. A., Sauerwein, R. W., Willems, J. L. & Monnens, L.A.H. (2000) Severe linear growth retardation in rural Zambian children: the influence of biological variables. Am. J. Clin. Nutr. 71:550-559.[Abstract/Free Full Text]

26. Oelofse, A., van Raaij, J.M.A., Benadé, A.J.S., Dhansay, M. A., Tolboom, J.J.M. & Hautvast, J.G.A.J. (2003) The effect of a micronutrient-fortified complementary food on micronutrient status, growth and development of 6- to 12-month-old disadvantaged urban South African infants. Int. J. Food Sci. Nutr. 54:399-407.[Medline]

27. Rosado, J. L., López, P., Muñoz, E., Martinez, H. & Allen, L. H. (1997) Zinc supplementation reduced morbidity, but neither zinc nor iron supplementation affected growth or body composition of Mexican preschoolers. Am. J. Clin. Nutr. 65:13-19.[Abstract/Free Full Text]

28. Rivera, J. A., González-Cossío, T., Flores, M., Romero, M., Rivera, M., Téllez-Rojo, M. M., Rosado, J. L. & Brown, K. H. (2001) Multiple micronutrient supplementation increases the growth of Mexican infants. Am. J. Clin. Nutr. 74:657-663.[Abstract/Free Full Text]

29. Beaton, G. H. & McCabe, G. P. (1999) Efficacy of Intermittent Iron Supplementation in the Control of Iron Deficiency Anemia in Developing Countries: An Analysis of Experience 1999 The Micronutrient Initiative Ottawa, Canada.

30. West, C. E. & Roodenburg, A.J.C. (1992) Role of vitamin A in iron metabolism. Voeding 53:201-205.

31. Ahmed, F., Khan, M. R. & Jackson, L.A.A. (2001) Concomitant supplemental vitamin A enhances the response to weekly supplemental iron and folic acid in anemic teenagers in urban Bangladesh. Am. J. Clin. Nutr. 74:108-115.[Abstract/Free Full Text]

32. van Stuijvenberg, M. E., Kruger, M., Badenhorst, C. J., Mansvelt, E.P.G. & Laubscher, J. A. (1997) Response to an iron fortification programme in relation to vitamin status in 6–12-year-old school children. Int. J. Food Sci. Nutr. 48:41-49.[Medline]

33. Meijia, L. A. & Chew, F. (1988) Hematological effect of supplementing anemic children with vitamin A alone and in combination with iron. Am. J. Clin. Nutr. 48:595-600.[Abstract/Free Full Text]

34. Alfrey, C. P. & Lane, M. (1970) The effect of riboflavin deficiency on erythropoiesis. Semin. Hematol. 7:49-54.[Medline]

35. Worthington-White, D. A., Behnke, M. & Gross, S. (1994) Premature infants require additional folate and vitamin B12 to reduce severity of anemia of prematurity. Am. J. Clin. Nutr. 60:930-935.[Abstract/Free Full Text]

36. Gallagher, P. G. & Ehrenkranz, R. A. (1995) Nutritional anemias in infancy. Clin. Perinatol. 22:671-692.[Medline]

37. Solomons, N. W. & Jacob, R. A. (1981) Studies on the bioavailability of zinc in humans: effect of heme and nonheme iron on the absorption of zinc. Am. J. Clin. Nutr. 34:475-482.[Abstract/Free Full Text]

38. Bloem, M. W. (1995) Interdependence of vitamin A and iron: an important association for programmes of anaemia control. Proc. Nutr. Soc. 54:501-508.[Medline]

39. Amazou, K. A., Chabi, N. W., Adjalla, C. E., Rodriguez-Gueant, R. M., Feillet, F., Villaume, C., Sanni, A. & Geant, J.-L. (2004) High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C to T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am. J. Clin. Nutr. 79:619-624.[Abstract/Free Full Text]

40. Faber, M. & Benadé, A.J.S. (1999) Nutritional status and dietary practices of 4–24-month-old children from a rural South African community. Public Health Nutr. 2:179-185.[Medline]

41. Oelofse, A., van Raaij, J.M.A., Benadé, A.J.S., Dhansay, M. A., Tolboom, J.J.M. & Hautvast, J.G.A.J. (2001) Disadvantaged black and coloured infants in two urban communities in the Western Cape, South Africa differ in micronutrient status. Public Health Nutr. 5:289-294.

42. Berger, J., Dyck, J. L., Aplogan, A., Schneider, D., Traissac, P. & Hercberg, H. (2000) Effect of daily iron supplementation on iron status, cell-mediated immunity, and incidence of infections in 6–36-month-old Togolese children. Eur. J. Clin. Nutr. 54:29-35.[Medline]

43. Osendarp, S.J.M., Raaij, M. A., Darmstadt, G. L., Baqui, A., Hautvast, J.G.A.J. & Fuchs, G. J. (2001) Zinc supplementation during pregnancy and effects on growth and morbidity in low birthweight infants: a randomised placebo control trial. Lancet 357:1080-1085.[Medline]




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
S. Adu-Afarwuah, A. Lartey, K. H Brown, S. Zlotkin, A. Briend, and K. G Dewey
Home fortification of complementary foods with micronutrient supplements is well accepted and has positive effects on infant iron status in Ghana
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 929 - 938.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Adu-Afarwuah, A. Lartey, K. H Brown, S. Zlotkin, A. Briend, and K. G Dewey
Randomized comparison of 3 types of micronutrient supplements for home fortification of complementary foods in Ghana: effects on growth and motor development
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 412 - 420.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. F. Walker, K. Kordas, R. J Stoltzfus, and R. E Black
Interactive effects of iron and zinc on biochemical and functional outcomes in supplementation trials
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 5 - 12.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smuts, C. M.
Right arrow Articles by Benadé, A. J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smuts, C. M.
Right arrow Articles by Benadé, A. J. S.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]